반응식
Cl[C:2]1[CH:7]=[C:6]([CH3:8])[N:5]=[C:4]([CH3:9])[C:3]=1[N+:10]([O-:12])=[O:11].[NH2:13][C:14]1[CH:19]=[CH:18][C:17]([CH2:20][CH2:21][OH:22])=[CH:16][CH:15]=1>>[CH3:9][C:4]1[C:3]([N+:10]([O-:12])=[O:11])=[C:2]([NH:13][C:14]2[CH:19]=[CH:18][C:17]([CH2:20][CH2:21][OH:22])=[CH:16][CH:15]=2)[CH:7]=[C:6]([CH3:8])[N:5]=1참가 물질
3
실험 절차
The title compound was prepared according to the procedure described in step 3 of Example 1 from 4-chloro-2,6-dimethyl-3-nitropyridine (Tanaka, A.; et al. J. Med. Chem., 1999, 41, 4408.) and 4-aminophenylethyl alcohol.
출처 및 근거
- ORD 기록
- ord-798890ecf1c84abe9a0bd25d7df15990
- 출처 데이터셋
- uspto-grants-2009_01
- 특허 번호
- US07479564B2
연결된 노트
불러오는 중…